샘플 요청 목록

 카트 문의
시장보고서
상품코드
1751259

내시경용 지혈 디바이스 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Endoscopic Hemostasis Devices Market Size, Share & Trends Analysis Report By Product (Ligation Clips, Ligation Bands, Injection Needles, Hemostatic Spray), By End Use, By Region, And Segment Forecasts, 2025 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

시장 규모와 동향 :

세계의 내시경용 지혈 디바이스 시장 규모는 2024년에 21억 달러로 추계되며, 2025-2030년에 CAGR 3.79%로 확대할 것으로 예측됩니다. 위정맥류, 소화성 궤양, 소화관암 등 소화관 질환의 유병률 증가가 내시경적 지혈 장비에 대한 수요 증가로 이어지고 있습니다.

예를 들어 소화성 궤양 증가로 인해 내시경 수술 중 효과적인 출혈 관리가 필요하며, 이는 시장 성장에 기여하고 있습니다. 이러한 질환의 유병률이 증가함에 따라 일반 외과수술에서 고급 지혈 장비의 필요성이 증가하여 시장의 추가 성장을 가속할 것입니다.

세계 의료 시스템은 생존율을 높이기 위해 암의 조기 발견 및 조기 치료를 위한 암 관리 프로토콜에 내시경적 시술을 도입하는 추세가 증가하고 있습니다. 이러한 추세와 전 세계 암 부담 증가는 내시경 수요를 증가시켜 시장 성장을 더욱 촉진할 것으로 예측됩니다. 또한 시장 제조업체들은 효과적인 암 치료를 위한 최첨단 기술을 갖추기 위해 지속적으로 혁신을 거듭하고 있으며, 증가하는 임상적 요구에 대응하기 위해 제품 라인을 확장하고 있습니다.

정부의 적극적인 홍보 캠페인과 암 검진 프로그램 등 정부의 적극적인 노력이 내시경용 지혈 장비 수요를 촉진할 것으로 예측됩니다. 예를 들어 CDC는 2021년 7월부터 2022년 6월까지 대장암 예방 프로그램(CRCCP) 협력 클리닉에서 약 19만 8,000명의 대장암 검진을 실시하여 전년 대비 35% 증가(5만 1,084건 추가 검진)했다고 보고했습니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 내시경용 지혈 디바이스 시장의 변수, 동향, 범위

  • 시장 계통 전망
    • 모시장 전망
    • 보조 시장 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
  • 내시경용 지혈 디바이스 : 시장 분석 툴
    • 업계 분석 - Porter의 산업 분석
    • PESTLE 분석
  • 테크놀러지 상황
  • 사례 연구 분석

제4장 내시경용 지혈 디바이스 시장 부문 분석, 제품별, 2018-2030년

  • 정의와 범위
  • 제품별 시장 점유율 분석, 2024년 및 2030년
  • 부문 대시보드
  • 내시경용 지혈 디바이스 세계 시장(제품별, 2018-2030년)
  • 결찰 클립
  • 결찰 밴드
  • 치질
  • 식도
  • 주사침
  • 지혈 스프레이
  • 서멀 프로브
  • 접촉 프로브
  • 비접촉 프로브
  • 아르곤 플라즈마 응고법(APC)
  • 고주파 절제(RFA)

제5장 내시경용 지혈 디바이스 시장 부문 분석, 최종 용도별, 2018-2030년

  • 정의와 범위
  • 최종 용도별 시장 점유율 분석, 2024년 및 2030년
  • 부문 대시보드
  • 세계의 내시경용 지혈 디바이스 시장(최종 용도별, 2018-2030년)
  • 병원
  • 외래 시설

제6장 내시경용 지혈 디바이스 시장 부문 분석, 지역별, 2018-2030년

  • 지역별 시장 점유율 분석, 2024년 및 2030년
  • 지역별 시장 대시보드
  • 지역별 시장 스냅숏
  • 내시경용 지혈 디바이스 시장 점유율 : 지역별, 2024년 및 2030년
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 노르웨이
    • 스웨덴
    • 덴마크
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 호주
    • 한국
    • 태국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 쿠웨이트

제7장 경쟁 구도

  • 주요 시장 참여 기업에 의한 최근 동향과 영향 분석
  • 기업 분류
  • 기업 개요
    • Boston Scientific Corporation
    • CONMED Corporation
    • Olympus Corporation
    • STERIS
    • Medtronic
    • MICRO-TECH(Nanjing) Co., Ltd.
    • B. Braun SE
    • Diversatek, Inc.
    • Cook
    • Duomed
KSA 25.06.26

Market Size & Trends:

The global endoscopic hemostasis devices market size was estimated at USD 2.10 billion in 2024 and is expected to expand at a CAGR of 3.79% from 2025 to 2030. The growing prevalence of gastrointestinal disorders, including gastric varices, peptic ulcers, and gastrointestinal cancers, is leading to a higher demand for endoscopic hemostasis devices.

For instance, the rise in peptic ulcer cases necessitates effective bleeding management during endoscopic procedures, which is contributing to market growth. As the prevalence of these conditions increases, the requirement for advanced hemostasis devices in general surgery will grow, driving further market growth.

Healthcare systems worldwide are increasingly incorporating endoscopic procedures into their cancer management protocols for early detection and treatment of cancer to improve survival rates. This trend and the rising global cancer burden are expected to boost endoscope demand, further driving market growth. Moreover, manufacturers in the market continuously innovate and expand their product lines to meet the growing clinical needs, aiming to equip them with the most advanced technology for effective cancer treatment.

Favorable government initiatives, including awareness campaigns and cancer screening programs, are expected to drive the demand for endoscopic hemostasis devices. For instance, the CDC reported that from July 2021 to June 2022, partner clinics in the Colorectal Cancer Control Program (CRCCP) screened nearly 198,000 individuals for colorectal cancer, marking a 35% increase (51,084 additional screenings) compared to the previous year.

Global Endoscopic Hemostasis Devices Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global endoscopic hemostasis devices market report based on product, end use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Ligation Clips
  • Ligation Bands
    • Hemorrhoidal
    • Esophageal
  • Injection Needles
  • Hemostatic Spray
  • Thermal Probes
    • Contact Probes
    • Noncontact Probes
  • Argon Plasma Coagulation (APC)
  • Radiofrequency Ablation (RFA)
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Outpatient Facilities
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Endoscopic Hemostasis Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Endoscopic Hemostasis Devices: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Technology Landscape
  • 3.5. Case Study Analysis

Chapter 4. Endoscopic Hemostasis Devices Market Segment Analysis, By Product, 2018-2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Endoscopic Hemostasis Devices Market, by Product, 2018 to 2030
  • 4.5. Ligation Clips
    • 4.5.1. Ligation Clips Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Ligation Bands
    • 4.6.1. Ligation Bands Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Hemorrhoidal
      • 4.6.2.1. Hemorrhoidal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Esophageal
      • 4.6.3.1. Esophageal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Injection Needles
    • 4.7.1. Injection Needles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Hemostatic Spray
    • 4.8.1. Hemostatic Spray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Thermal Probes
    • 4.9.1. Thermal Probes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.9.2. Contact Probes
      • 4.9.2.1. Contact Probes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.9.3. Noncontact Probes
      • 4.9.3.1. Noncontact Probes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.10. Argon Plasma Coagulation (APC)
    • 4.10.1. Argon Plasma Coagulation (APC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.11. Radiofrequency Ablation (RFA)
    • 4.11.1. Radiofrequency Ablation (RFA) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Endoscopic Hemostasis Devices Market Segment Analysis, By End Use, 2018-2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. End Use Market Share Analysis, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Endoscopic Hemostasis Devices Market, by End Use, 2018 to 2030
  • 5.5. Hospitals
    • 5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Outpatient Facilities
    • 5.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Endoscopic Hemostasis Devices Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Regional Market Snapshot
  • 6.4. Endoscopic Hemostasis Devices Market Share by Region, 2024 & 2030:
  • 6.5. North America
    • 6.5.1. North America endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Scenario
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. U.S. endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Scenario
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Canada endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Scenario
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Mexico endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. Europe endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.6.2. UK
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Scenario
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. UK endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Scenario
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Germany endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.6.4. France
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Scenario
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. France endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Scenario
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Italy endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Scenario
      • 6.6.6.3. Competitive Scenario
      • 6.6.6.4. Spain endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.6.7. Norway
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Scenario
      • 6.6.7.3. Competitive Scenario
      • 6.6.7.4. Norway endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Regulatory Scenario
      • 6.6.8.3. Competitive Scenario
      • 6.6.8.4. Sweden endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.6.9. Denmark
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Regulatory Scenario
      • 6.6.9.3. Competitive Scenario
      • 6.6.9.4. Denmark endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Regulatory Scenario
      • 6.7.1.3. Competitive Scenario
      • 6.7.1.4. Japan endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Scenario
      • 6.7.2.3. Competitive Scenario
      • 6.7.2.4. China endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Scenario
      • 6.7.3.3. Competitive Scenario
      • 6.7.3.4. India endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Regulatory Scenario
      • 6.7.4.3. Competitive Scenario
      • 6.7.4.4. Australia endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Regulatory Scenario
      • 6.7.5.3. Competitive Scenario
      • 6.7.5.4. South Korea endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Regulatory Scenario
      • 6.7.6.3. Competitive Scenario
      • 6.7.6.4. Thailand endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key Country Dynamics
      • 6.8.1.2. Regulatory Scenario
      • 6.8.1.3. Competitive Scenario
      • 6.8.1.4. Brazil endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Scenario
      • 6.8.2.3. Competitive Scenario
      • 6.8.2.4. Argentina endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key Country Dynamics
      • 6.9.1.2. Regulatory Scenario
      • 6.9.1.3. Competitive Scenario
      • 6.9.1.4. South Africa endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key Country Dynamics
      • 6.9.2.2. Regulatory Scenario
      • 6.9.2.3. Competitive Scenario
      • 6.9.2.4. Saudi Arabia endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key Country Dynamics
      • 6.9.3.2. Regulatory Scenario
      • 6.9.3.3. Competitive Scenario
      • 6.9.3.4. UAE endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key Country Dynamics
      • 6.9.4.2. Regulatory Scenario
      • 6.9.4.3. Competitive Scenario
      • 6.9.4.4. Kuwait endoscopic hemostasis devices market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Profiles
    • 7.3.1. Boston Scientific Corporation
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Platform benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. CONMED Corporation
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Platform benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Olympus Corporation
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Platform benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. STERIS
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Platform benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Medtronic
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Platform benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. MICRO-TECH (Nanjing) Co., Ltd.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Platform benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. B. Braun SE
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Platform benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Diversatek, Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Platform benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Cook
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Platform benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Duomed
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Platform benchmarking
      • 7.3.10.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제